HESTERBIO.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 08:14):

Stats
Šios dienos apimtis	10 748.00
Vidutinė apimtis	9 665.00
Rinkos kapitalizacija	13.81B
EPS	INR0 ( 2024-02-02 )
Kita pelno data	( INR0 ) 2024-05-14
Last Dividend	INR8.00 ( 2023-09-13 )
Next Dividend	INR0 ( N/A )
P/E	72.20
ATR14	INR5.24 (0.32%)

Tūris Koreliacija

Ilgas: -0.25 (neutral)

Trumpas: -0.18 (neutral)

Signal:(58.209) Neutral

Hester Biosciences Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Hester Biosciences Koreliacija - Valiuta/Žaliavos

-0.41
( neutral )

0.34
( neutral )

-0.03
( neutral )

0.45
( neutral )

0.24
( neutral )

0.52
( weak )

Hester Biosciences Finansinės ataskaitos

Annual	2022
Pajamos:	INR2.66B
Bruto pelnas:	INR1.89B (70.88 %)
EPS:	INR31.30

FY	2022
Pajamos:	INR2.66B
Bruto pelnas:	INR1.89B (70.88 %)
EPS:	INR31.30

FY	2022
Pajamos:	INR2.35B
Bruto pelnas:	INR1.66B (70.70 %)
EPS:	INR46.22

FY	2021
Pajamos:	INR2.14B
Bruto pelnas:	INR1.58B (73.69 %)
EPS:	INR40.47

Financial Reports:

No articles found.

Hester Biosciences Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR10.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR8.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Hester Biosciences Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.34 - low (11.08%) | Divividend Growth Potential Score: 3.09 - Decrease likely (38.25%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR3.10	2015-09-10
Last Dividend	INR8.00	2023-09-13
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	14	--
Total Paid Out	INR68.10	--
Avg. Dividend % Per Year	0.31%	--
Score	1.73	--
Div. Sustainability Score	3.34
Div.Growth Potential Score	3.09
Div. Directional Score	3.21	--

Next Divdend (Est)
(2024-08-26)

INR8.28 Estimate 3.41 %

Dividend Stability

0.27 Very Poor

Dividend Score

1.73

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2015	INR0	0.00%
2016	INR0	0.00%
2017	INR0	0.00%
2018	INR10.00	0.65%
2019	INR7.00	0.60%
2020	INR6.60	0.46%
2021	INR10.00	0.59%
2022	INR10.00	0.40%
2023	INR8.00	0.45%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
SMLT.NS	Dividend Knight	2023-08-09	Semi-Annually	3	0.64%
MIDHANI.NS	Dividend Junior	2023-09-22	Semi-Annually	7	1.04%
HAVELLS.NS	Dividend Junior	2023-06-02	Annually	23	0.43%
BECTORFOOD.NS	Dividend Junior	2023-09-22	Semi-Annually	4	0.39%
PUNJABCHEM.NS	Dividend Junior	2023-07-27	Sporadic	18	0.16%
KENNAMET.NS	Dividend Knight	2023-05-25	Annually	4	0.76%
ELECTCAST.NS	Dividend Junior	2023-09-04	Annually	23	1.51%
AHLUCONT.NS	Dividend Junior	2023-09-22	Sporadic	15	0.04%
SUNPHARMA.NS	Dividend Junior	2023-07-28	Semi-Annually	29	0.77%
NAVA.NS	Dividend Knight	2023-07-24	Annually	23	2.35%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0631	1.500	8.74	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0640	1.500	-0.400	-0.600	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	3.05	1.000	9.98	9.98	[3 - 30]
operatingCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
freeCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.671	1.000	2.15	2.15	[0.2 - 0.8]
operatingProfitMarginTTM	0.148	1.000	9.04	9.04	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.34

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	77.90	1.000	2.23	0	[1 - 100]
returnOnEquityTTM	0.0640	2.50	-0.257	-0.600	[0.1 - 1.5]
freeCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
dividendYielPercentageTTM	0.473	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	44.19	2.00	10.00	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-2.41	1.500	-10.00	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.128	1.000	9.29	0	[0.1 - 0.5]
Total Score				3.09

Hester Biosciences

Hester Biosciences Limited manufactures and trades in veterinary vaccines and animal health products in India and internationally. It operates in two segments, Poultry Healthcare and Animal Healthcare. The company provides poultry vaccines for diseases, such as newcastle disease, infectious bronchitis, infectious bursal disease, fowl pox, egg drop syndrome, reo, marek's disease, infectious coryza, fowl cholera, mycoplasma gallisepticum, inclusion body hepatitis, avian encephalomyelitis, etc. It also offers vaccines for large animals comprising Goat Pox, Peste des Petits Ruminants, Brucellosis, Mastitis, Metritis, and various infectious diseases, as well as infections, reproductive disorders, theileriosis, parasitic diseases, etc. In addition, the company provides feed supplements, such as toxin binder, trace minerals, enzyme preparation, and bypass fat; disinfectants for farms and equipment, and water sanitizers; nutrition products consisting of mineral mixtures, fertility supplements, and growth tonics; and herbal products, including growth promoters, herbal replacers for choline chloride, stress relievers and immunity boosters, respiratory stimulants, liver tonics, wound healing preparations, uterine tonics, digestive tonics and anti-bloat solutions, ectoparasiticide preparations, anti-mastitis, and anti-prolapse preparations. Hester Biosciences Limited was incorporated in 1987 and is headquartered in Ahmedabad, India.